Evaluation of the relationship between polymorphisms in <i>CYP2C19</i> and the single‐dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter study-Reference-Cited by-同舟云学术

Evaluation of the relationship between polymorphisms in CYP2C19 and the single‐dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter study

Published:2022-03-25 Issue:6 Volume:15 Page:1439-1448
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Zhou Shuang¹²,Xie Ran¹,Zhang Xiaodan¹,He Xu¹²,Huang Jie³,Jungang Yin⁴,Liao Man⁵,Ding Ying⁶,Yang Dandan⁷,Liu Ying⁸,Zhang Qian⁹,Yang Guoping³,Liu Fang⁴,Guan Shengjiang⁵,He Qing⁶,Lou Honggang⁷,Gong Fengyun⁸,Meng Xianmin⁹,Xiang Qian¹,Zhao Xia¹,Cui Yimin¹¹⁰

Affiliation:

1. Department of Pharmacy Peking University First Hospital Beijing China

2. Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Science Peking University Beijing China

3. Center for Clinical Pharmacology The Third Xiangya Hospital Central South University Changsha Hunan China

4. GCP Center Jiangsu Province Hospital of Chinese Medicine Nanjing China

5. Hebei Provincial Hospital of Traditional Chinese Medicine Shijiazhuang China

6. The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi, Jiangsu China

7. Center of Clinical Pharmacology The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China

8. The Office of Drug Clinical Trial Institution Wuhan Jinyintan Hospitial Wuhan China

9. Department of Pharmacy Shanghai Public Health Clinical Center Fudan University Shanghai China

10. Institute of Clinical Pharmacology Peking University Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13255

Reference27 articles.

1. Pharmacokinetics, Metabolism and Interactions of Acid Pump Inhibitors

2. COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES

3. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

4. CYP2C19 Genotype and Phenotype Determined with Omeprazole in Patients with Acid-Related Disorders with and withoutHelicobacter pyloriInfection

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study;Clinical Pharmacology & Therapeutics;2024-01-22

2. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice;Journal of Clinical Laboratory Analysis;2023-04

3. Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers;Scientific Reports;2023-01-20